Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

23.09
+0.81003.64%
Post-market: 22.94-0.1501-0.65%19:59 EDT
Volume:77.48M
Turnover:1.77B
Market Cap:131.28B
PE:16.69
High:23.15
Open:22.23
Low:22.18
Close:22.28
Loading ...
May 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2025

Proposed Sale Of Securities

Form 144 | Former Officer Mikael Dolsten proposes to sell 55,000 shares, with a total value of approximately $1.31 Million.
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 22, 2024

Correspondence

Form CORRESP - Correspondence
Aug 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 30, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 26, 2024

Major Issues Report

Form 8-K - Current report
Jul 10, 2024

Major Issues Report

Form 8-K - Current report
Jul 01, 2024

Major Issues Report

Form 8-K - Current report